Journal article · 2026 · Open access
Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation
New England Journal of Medicine, 394(13), 1270–1280 · Published 18 March 2026 · DOI 10.1056/nejmoa2513310
In brief
“Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation” is a 2026 journal article by Ulf Landmesser and 28 co-authors, published in New England Journal of Medicine. OpenAlex counts 135 citations as of 16 November 2026. It is open access: the full text is free to read at GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen).
- Citations
- 135
- Most cited in
- 2026 (133)
- Field-weighted impact
- 461.32
- References
- 30
- Authors
- 29
Abstract
BackgroundCatheter-based closure of the left atrial appendage is an alternative to oral anticoagulation for stroke prevention in patients with atrial fibrillation. The effectiveness of this strategy, as compared with physician-directed best medical care, in patients at high risk for stroke and bleeding is unknown. MethodsIn this multicenter randomized trial conducted in Germany, we assigned patients with atrial fibrillation and a high risk of stroke and bleeding to undergo left atrial appendage closure or to receive physician-directed best medical care (including direct oral anticoagulants, if eligible). The primary end point, tested for noninferiority, was a composite of stroke (ischemic or hemorrhagic), systemic embolism, major bleeding, or cardiovascular or unexplained death, assessed in a time-to-event analysis. The noninferiority margin was a hazard ratio of 1.3. Research Summary Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation ResultsA total of 912 adult patients underwent randomization. The primary end-point analysis included 446 patients who were assigned to undergo left atrial appendage closure (device group) and 442 who were assigned to physician-directed best medical care (medical-therapy group). The mean (±SD) age was 77.9±7.1 years; 38.6% of the patients were women, the mean CHA2DS2-VASc score was 5.2±1.5 (range, 0 to 9, with higher scores indicating a greater risk of stroke), and the mean HAS-BLED score was 3.0±0.9 (range, 0 to 9, with higher scores indicating higher risk of bleeding). After a median follow-up of 3 years (interquartile range, 1.7 to 4.7), a first primary end-point event had occurred in 155 patients (incidence per 100 patient-years, 16.8) in the device group and in 127 patients (incidence per 100 patient-years, 13.3) in the medical-therapy group (difference in restricted mean survival time, −0.36 years; 95% confidence interval, −0.70 to −0.01; P=0.44 for noninferiority). Serious adverse events occurred in 368 patients (82.5%) in the device group and 342 (77.4%) in the medical-therapy group. ConclusionsAmong patients with atrial fibrillation at high risk for stroke and bleeding, left atrial appendage closure was not noninferior to physician-directed best medical care with regard to a composite end point of stroke, systemic embolism, major bleeding, or cardiovascular or unexplained death. (Funded by the German Center for Cardiovascular Research; CLOSURE-AF ClinicalTrials.gov number, NCT03463317.)
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Landmesser, U., Skurk, C., Kirchhof, P. F., Lewalter, T., Hartung, J. J., Rroku, A., Pieske, B. M., Brachmann, J., Akın, İ., Jacobshagen, C., Meder, B., Zeiher, A. M., Anker, S. D., Thiele, H., Blankenberg, S., Maßberg, S., Schunkert, H., Frey, N., Joost, A., . . . Eitel, I. (2026). Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation. New England Journal of Medicine, 394(13), 1270–1280. https://doi.org/10.1056/nejmoa2513310
MLA 9
Landmesser, Ulf, et al. “Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation.” New England Journal of Medicine, vol. 394, no. 13, 2026, pp. 1270–1280. https://doi.org/10.1056/nejmoa2513310.
Chicago
Landmesser, Ulf, Carsten Skurk, Paulus F. Kirchhof, Thorsten Lewalter, Johannes Jakob Hartung, Andi Rroku, Burkert Mathias Pieske, et al. 2026. “Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation.” New England Journal of Medicine 394 (13): 1270–1280. https://doi.org/10.1056/nejmoa2513310.
Harvard
Landmesser, U. et al. (2026) ‘Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation’, New England Journal of Medicine, 394(13), pp. 1270–1280. doi:10.1056/nejmoa2513310.
IEEE
U. Landmesser et al., “Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation,” New England Journal of Medicine, vol. 394, no. 13, pp. 1270–1280, 2026, doi: 10.1056/nejmoa2513310.
BibTeX
@article{landmesser2026left,
title = {{Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation}},
author = {Landmesser, Ulf and Skurk, Carsten and Kirchhof, Paulus F. and Lewalter, Thorsten and Hartung, Johannes Jakob and Rroku, Andi and Pieske, Burkert Mathias and Brachmann, Johannes and Akın, İbrahim and Jacobshagen, Claudius and Meder, Benjamin and Zeiher, Andreas Michael and Anker, Stefan D. and Thiele, Hölger and Blankenberg, Stefan and Maßberg, Steffen and Schunkert, Heribert and Frey, Norbert and Joost, Alexander and Bergmann, Martin and von Bardeleben, Ralph Stephan and Friede, Tim and Placzek, Marius and Suling, Anna Isabella and Hæusler, Karl Georg and Endres, Matthias and Wegscheider, Karl and Boldt, Leif‐Hendrik and Eitel, Ingo},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {13},
pages = {1270--1280},
doi = {10.1056/nejmoa2513310},
url = {https://doi.org/10.1056/nejmoa2513310}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 1 | |
| 2024 | 1 | |
| 2026 | 133 |
Its field-weighted citation impact is 461.32: it has been cited 461.32 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- left atrial appendage closure
- atrial fibrillation
- stroke prevention
- oral anticoagulation
- direct oral anticoagulants
- non-inferiority
- high bleeding risk
- systemic embolism
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Landmesser, U., Skurk, C., Kirchhof, P. F., Lewalter, T., Hartung, J. J., Rroku, A., Pieske, B. M., Brachmann, J., Akın, İ., Jacobshagen, C., Meder, B., Zeiher, A. M., Anker, S. D., Thiele, H., Blankenberg, S., Maßberg, S., Schunkert, H., Frey, N., Joost, A., . . . Eitel, I. (2026). Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation. New England Journal of Medicine, 394(13), 1270–1280. https://doi.org/10.1056/nejmoa2513310
How many times has this paper been cited?
135 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen): sign in and open the full text from this page.
Who wrote this paper?
Ulf Landmesser, Carsten Skurk, Paulus F. Kirchhof, Thorsten Lewalter, Johannes Jakob Hartung, Andi Rroku, Burkert Mathias Pieske, Johannes Brachmann, İbrahim Akın, Claudius Jacobshagen, Benjamin Meder, Andreas Michael Zeiher and 17 more.
What is the DOI of this paper?
10.1056/nejmoa2513310, permanently at https://doi.org/10.1056/nejmoa2513310. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.